Ashbocking: Scientists find beetroot juice lowers blood pressure using samples made by James White Drinks in Suffolk
A daily drink of beetroot juice lowers blood pressure, scientists using test samples made in Suffolk have found.
Researchers at Queen Mary University in London (QMUL) used juice supplied by James White Drinks, which makes a Beet It range of beetroot drinks, for its clinical trials.
The firm, based at Ashbocking, near Ipswich, supplies research bodies around the world with test samples of beetroot juice, as well as making a range of fruit drinks for the general public.
The scientists at Queen Mary found that drinking a daily cup of beetroot juice has been shown to significantly lower blood pressure among patients with high blood pressure.
Patients with high blood pressure who drank a daily 250ml glass of beetroot juice experienced an average decrease in blood pressure of about 8/4 mmHg, which for many patients brought their blood pressure levels back into the ‘normal’ range.
This is due to beetroot – and other leafy green vegetables such as lettuce and cabbage – containing high levels of a substance called inorganic nitrate.
The researchers believe the findings are potentially very important as large-scale observational studies suggest that each 2mmHg increase in blood pressure increases the likelihood of death from heart disease by 7% and stroke by 10%.
- 1 WATCH: 'Unplayable' delivery from Suffolk bowler goes viral
- 2 Seven players who could leave Ipswich Town this summer
- 3 New landlord hopes to make Suffolk pub 'centre' of village community
- 4 A14 westbound reopens after crash caused 7 miles of delays
- 5 Conveyor belt which carried pig carcases across Suffolk A-road is demolished
- 6 Is this tearoom near Ipswich one of Suffolk’s best-kept secrets?
- 7 Mercedes and Vauxhall flip over after crash in busy Ipswich road
- 8 Woman freed from vehicle after car overturns near to shops
- 9 Plans for 20 homes in Suffolk village unanimously refused
- 10 Boy, 10, asked to get in car by two men near Sudbury
This is the first evidence of a long-lasting blood pressure reduction with dietary nitrate supplementation in a relevant patient group. The average reduction in blood pressure through a single anti-hypertensive drug is 9/5 mmHg. Therefore, these findings suggest a role for dietary nitrate as an effective, easy and affordable treatment in managing blood pressure with similar results to drug treatment.
Professor Amrita Ahluwalia, lead author at Queen Mary University of London, said: “Diseases of the heart and blood vessels – which can cause heart attacks and strokes - remain the biggest cause of death worldwide. However, unlike some other serious illnesses, we are fortunate in that we can make certain lifestyle changes which dramatically improve our heart and blood vessel health.
“This research has proven that a daily inorganic nitrate dose can be as effective as medical intervention in reducing blood pressure and the best part is we can get it from beetroot and other leafy green vegetables.”
James White Drinks founder Lawrence Mallinson said: “Beet It is very proud to have been involved in such important medical research.
“This is the fourth paper by QMUL to be published by the American Heart Association and it is the one that the medical profession will really take note of. It demonstrates that beetroot juice - specifically the nitrate content of beetroot juice - significantly reduces blood pressure for those with high blood pressure when taken on a regular and on going daily basis even when taken in conjunction with existing blood pressure reduction medication.
“A glass of beetroot juice a day really does keep the doctor away!”
The double-blind Phase Two clinical trial, published in the journal Hypertension and funded by the British Heart Foundation, was carried out among 64 patients aged 18 – 85 years. Half of the patients were taking prescribed anti-hypertensive drugs but were failing to reach their target blood pressure, and the other half had been identified as having high blood pressure but not yet on medication.
Patients were randomly assigned a daily dietary supplementation for four weeks – half received the dietary nitrate (250ml beetroot juice) and the other half received a placebo (250ml nitrate-free beetroot juice). They were also monitored for two weeks both before and after the study.
During the study, patients in the intervention group also experienced an improvement of around 20% in blood vessel dilation capacity and around a 10% reduction in arterial stiffness. These changes in blood vessel function have been shown, by other studies, to be associated with substantial reductions in heart disease. There were no adverse side effects from the daily dietary nitrate.
In the two weeks after the study period, the blood pressure readings among patients in the intervention group returned to their previous high levels.
Professor Ahluwalia said: “These findings are exciting because we’ve now tested the effectiveness of dietary nitrate in reducing blood pressure in 64 patients, over a sustained period of time, and found it works. Plus it’s so easy for patients to work this into their daily lives and see a positive benefit. The next step will hopefully be to run a large-scale Phase Three clinical trial so we can determine whether the impact of dietary nitrate is sustained long-term, and whether this should be recommended in NHS guidelines.
“It is hugely beneficial for people to be able to take steps in controlling their blood pressure through non-clinical means such as eating vegetables. We know many people don’t like taking drugs life-long when they feel ok, and because of this, medication compliance is a big issue.
“For those looking to work dietary nitrate into their daily diets, the trick is not to boil the vegetables – as dietary nitrate is water soluble – but steaming, roasting or drinking in a juice all has a positive effect.”
Dr Shannon Amoils, senior research adviser at the British Heart Foundation, which funded the study, said:“The possibility of using a natural product, rather than another pill, to help lower blood pressure, is very appealing. The trial is small however, and the next step will be to see if this result can be repeated in a much larger group of people with high blood pressure and over a longer period of time.”